ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 48 filers reported holding ELOXX PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $70,000 | -23.9% | 21,100 | -8.7% | 0.00% | – |
| Q4 2020 | $92,000 | +50.8% | 23,100 | 0.0% | 0.00% | – |
| Q3 2020 | $61,000 | -19.7% | 23,100 | -8.0% | 0.00% | – |
| Q2 2020 | $76,000 | +81.0% | 25,100 | +17.3% | 0.00% | – |
| Q1 2020 | $42,000 | -71.4% | 21,400 | +7.0% | 0.00% | – |
| Q4 2019 | $147,000 | +63.3% | 20,000 | 0.0% | 0.00% | – |
| Q3 2019 | $90,000 | -47.7% | 20,000 | +15.6% | 0.00% | – |
| Q2 2019 | $172,000 | +13.2% | 17,300 | +33.1% | 0.00% | – |
| Q1 2019 | $152,000 | – | 13,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Clal Insurance Enterprises Holdings Ltd | 14,626 | $27 | 0.00% |